Ucb S.A.
Records under this name other than patents Ucb S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,486,662 | DNA encoding antibody molecules having specificity for human IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,096,668 | Methods for making antibody molecules having specificity for human IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,631,015 | Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,633,194 | Pharmaceutical composition of piperazine derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,075,889 | Antibody molecules having specificity for human IL-6 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,208,349 | Lipocalin 2 as a Biomarker for IL-17 Inhibitor Therapy Efficacy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,466,324 | Lipocalin 2 as a Biomarker for IL-17 Inhibitor Therapy Efficacy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,202,405 | Fused Pentacyclic Imidazole Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,906,919 | Fused Pentacyclic Imidazole Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,705,094 | TNF Receptor Signaling Modulator Assay Formerly held In force · High confidence | In force | High confidence |